Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayani, H.
Right arrow Articles by Ramírez, O. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayani, H.
Right arrow Articles by Ramírez, O. T.
Stem Cells, Vol. 16, No. 2, 127-135, March 1998
© 1998 AlphaMed Press

Kinetics of Hematopoiesis in Dexter-Type Long-Term Cultures Established from Human Umbilical Cord Blood Cells

Hector Mayania, Margarita Gutiérrez-Rodrígueza, Laura Espinozaa, Edith López-Chalinib, Alejandra Huerta-Zepedaa, Eugenia Floresa, Elizabeth Sánchez-Vallea, Fernando Luna-Bautistaa, Ignacio Valenciaa, Octavio T. Ramírezb

a Oncological Research Unit, Oncology Hospital, National Medical Center, IMSS, Mexico City, Mexico;
b Bioengineering Department, Institute of Biotechnology, UNAM, Cuernavaca, Mexico

Key Words. Bone marrow • Cord blood • Dexter culture • Hematopoiesis • Progenitors • Stroma

Dr. Hector Mayani, Oncological Research Unit, Oncology Hospital, National Medical Center, Av. Cuauhtemoc 330, Mexico, D.F. 06720.

In the present study, we have established Dexter-type long-term cultures (D-LTC) from human umbilical cord blood (UCB) and followed the kinetics of different hematopoietic progenitor cells (HPCs)—including multipotent (colony forming unit [CFU]- Mixture), erythroid (CFU-erythroid, BFU-E), and myeloid (CFU-granulocyte, CFU-macrophage, CFU-granulocyte/macrophage) progenitors as well as of morphologically recognizable erythroid, myeloid and lymphoid cells—during a nine-week culture period. D-LTC were also established from adult bone marrow (BM) as controls. On day 0, both UCB and BM showed similar total numbers of HPCs (about 310/105 cells), however, UCB showed a higher proportion of primitive HPCs (i.e., CFU-Mixture, CFU-granulocyte/macrophage and BFU-E). A poor adherent cell layer, consisting almost exclusively of macrophages, was developed in UCB D-LTC and this correlated with a continuous decline in HPC numbers throughout the culture period. In contrast, adherent cell numbers in BM D-LTC, including fibroblasts and macrophages, were two- to fourfold higher than in UCB cultures, and the numbers of HPCs were also significantly higher, reaching plateau levels between weeks 6 and 9. In both types of cultures, erythroid and multipotent progenitors declined relatively fast, reaching undetectable levels after five weeks of culture. Myeloid progenitors, on the other hand, were sustained longer (always at higher levels in BM cultures) and were still detected by week 9. Among myeloid progenitors, a shift towards the predominance of macrophage HPCs was observed, both in UCB and BM D-LTC, and this correlated with an increase in the proportion of mature monocytes and macrophages. Taken together, our results indicate that myeloid progenitor cell growth is deficient in UCB D-LTC and suggest that this is due to the impaired development of an adherent cell layer, unable to provide the factors and conditions required for their growth. Interestingly, throughout the culture period the total numbers of multipotent and erythroid progenitors were similar both in UCB and BM cultures regardless of the number and types of adherent cells present; this suggests that the stroma developed in D-LTC is not sufficient for the proliferation of these progenitor cells.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
J. J. Minguell and A. Erices
Mesenchymal Stem Cells and the Treatment of Cardiac Disease
Experimental Biology and Medicine, January 1, 2006; 231(1): 39 - 49.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Jaroscak, K. Goltry, A. Smith, B. Waters-Pick, P. L. Martin, T. A. Driscoll, R. Howrey, N. Chao, J. Douville, S. Burhop, et al.
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System
Blood, June 15, 2003; 101(12): 5061 - 5067.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. M. Farese, T. J. MacVittie, L. Roskos, and R. B. Stead
Hematopoietic Recovery Following Autologous Bone Marrow Transplantation in a Nonhuman Primate: Effect of Variation in Treatment Schedule with PEG-rHuMGDF
Stem Cells, January 1, 2003; 21(1): 79 - 89.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Gutiérrez-Rodríguez, E. Reyes-Maldonado, and H. Mayani
Characterization of the Adherent Cells Developed in Dexter-Type Long-Term Cultures from Human Umbilical Cord Blood
Stem Cells, January 1, 2000; 18(1): 46 - 52.
[Abstract] [Full Text]


Home page
Stem CellsHome page
H. Mayani and P. M. Lansdorp
Biology of Human Umbilical Cord Blood-Derived Hematopoietic Stem/Progenitor Cells
Stem Cells, May 1, 1998; 16(3): 153 - 165.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1998 by AlphaMed Press.